Tag: DVT

COVID-19

Study finds increased risk of serious blood clots up to six...

A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
CardioVascular Systems CSI

Cardiovascular Systems partners with Innova Vascular to develop full line of...

Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.  According to a...

AVF 2022: Emerging autogenous venous valve formation system sees “continual improvement”

An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...

Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice

 At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...
vetex

New DVT device completes first-in-human trial

The first-in-human case using the new deep vein thrombosis (DVT) device Vetex thrombectomy catheter (Vetex Medical) has recently been completed in a multicentre study....

New developments in treatment of deep venous thrombosis

 An analysis ATTRACT has just been published in the journal, Circulation in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT...
PTS

New ATTRACT data show catheter-based therapy significantly reduces leg symptoms and...

A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous...

New products showcased at SIR 2018

There were several devices in the New Product Showcase at the Society of Interventional Radiology's Annual Scientific Meeting in Los Angeles, USA. Among these...

ACCESS PTS study demonstrates Ekos’ efficacy in treatment of post-thrombotic syndrome

BTG has highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th annual scientific sessions (14–17 June, New...

ATTRACT fails to meet primary endpoint, but experts agree results are...

Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...

ATTRACT trial results to be presented at SIR 2017 meeting

Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...
Interventional News for specialists

BTG receives US FDA 510(k) clearance for Ekos control unit 4.0

BTG has announced that US FDA 510(k) clearance has been granted to the Ekos control unit 4.0. The Ekos system includes an ultrasonic device...

First pulmonary embolism patients in Hong Kong treated with the BTG’s...

The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an...